2BB score and signals
Monte Rosa Therapeutics, Inc.’s current 2BB score is 9 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 15 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 61 | High |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2019 |
| Employees | 187 |
| 52-week range | $4.12 – $25.77 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-15 | — | -0.5202 | — | $7.23M |
| 2026-11-05 | — | -0.3713 | — | $24.68M |
| 2026-08-06 | — | -0.3924 | — | $5.63M |
| 2026-05-06 | — | -0.4851 | — | $3.06M |
2BBBullish & Bearish